{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:25:39Z","timestamp":1791318339222,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Anti-melanoma Association (ACM Onlus)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ejphar.2013.08.039","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T20:31:03Z","timestamp":1379104263000},"page":"154-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Anticancer activity of anandamide in human cutaneous melanoma cells"],"prefix":"10.1016","volume":"718","author":[{"given":"Barbara","family":"Adinolfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Romanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Chicca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fogli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Nieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.08.039_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0083-6729(09)81018-2","article-title":"Changes in the Endocannabinoid System may give insight into new and effective treatments for cancer","volume":"81","author":"Alpini","year":"2009","journal-title":"Vitamins and Hormones"},{"key":"10.1016\/j.ejphar.2013.08.039_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnbeh.2012.00009","article-title":"The endocannabinoid system: an overview","volume":"6","author":"Battista","year":"2012","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.ejphar.2013.08.039_bib3","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1096\/fj.06-6638fje","article-title":"Cannabinoid receptors as novel targets for the treatment of melanoma","volume":"20","author":"Bl\u00e1zquez","year":"2006","journal-title":"FASEB Journal"},{"key":"10.1016\/j.ejphar.2013.08.039_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.ejphar.2013.08.039_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI200316116","article-title":"Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors","volume":"111","author":"Casanova","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.ejphar.2013.08.039_bib6","first-page":"551","article-title":"Rofecoxib [Vioxx, MK-0966; 4-(4\u2032-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles","volume":"290","author":"Chan","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.ejphar.2013.08.039_bib7","doi-asserted-by":"crossref","first-page":"34660","DOI":"10.1074\/jbc.M112.373241","article-title":"Evidence for bidirectional endocannabinoid transport across cell membranes","volume":"287","author":"Chicca","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ejphar.2013.08.039_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phrs.2009.02.010","article-title":"The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploration","volume":"60","author":"Di Marzo","year":"2009","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.ejphar.2013.08.039_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semcancer.2007.12.008","article-title":"The endocannabinoid system in cancer-potential therapeutic target?","volume":"18","author":"Flygare","year":"2008","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.ejphar.2013.08.039_bib10","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.febslet.2006.02.024","article-title":"Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism","volume":"580","author":"Fogli","year":"2006","journal-title":"FEBS Letters"},{"key":"10.1016\/j.ejphar.2013.08.039_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11745-012-3684-z","article-title":"Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases","volume":"47","author":"Forsell","year":"2012","journal-title":"Lipids"},{"key":"10.1016\/j.ejphar.2013.08.039_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tips.2012.01.001","article-title":"Anandamide uptake explained?","volume":"33","author":"Fowler","year":"2012","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.ejphar.2013.08.039_bib13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2174\/092986711795471374","article-title":"The endocannabinoid system in the cancer therapy: an overview","volume":"18","author":"Grimaldi","year":"2011","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.ejphar.2013.08.039_bib14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1476-5381.2011.01327.x","article-title":"The endocannabinoid system and cancer: therapeutic implication","volume":"163","author":"Guindon","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.ejphar.2013.08.039_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2407-12-92","article-title":"The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action","volume":"12","author":"Hamtiaux","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2013.08.039_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000336872","article-title":"Off-target cannabinoid effects mediated by GPR55","volume":"89","author":"Henstridge","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2013.08.039_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10555-011-9318-8","article-title":"Cannabinoids, endocannabinoids, and cancer","volume":"30","author":"Hermanson","year":"2011","journal-title":"Cancer and Metastasis Reviews"},{"key":"10.1016\/j.ejphar.2013.08.039_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/labinvest.2011.62","article-title":"Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor","volume":"91","author":"Huang","year":"2011","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.ejphar.2013.08.039_bib19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s12253-012-9515-y","article-title":"Revisiting CB1 receptor as drug target in human melanoma","volume":"18","author":"Kenessey","year":"2012","journal-title":"Pathology and Oncology Research"},{"key":"10.1016\/j.ejphar.2013.08.039_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mc.20770","article-title":"Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade","volume":"51","author":"Kuc","year":"2012","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.ejphar.2013.08.039_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0707423","article-title":"Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors","volume":"152","author":"O\u2019Sullivan","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.ejphar.2013.08.039_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.imbio.2009.09.007","article-title":"Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease","volume":"215","author":"O\u2019Sullivan","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejphar.2013.08.039_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1471-4159.2005.03013.x","article-title":"Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue","volume":"93","author":"Petersen","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.ejphar.2013.08.039_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","volume":"12","author":"Piomelli","year":"2006","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/j.ejphar.2013.08.039_bib25","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2174\/092986710790980014","article-title":"From surface to nuclear receptors: the endocannabinoid family extends its assets","volume":"17","author":"Pistis","year":"2010","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.ejphar.2013.08.039_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tips.2008.12.004","article-title":"The enigmatic pharmacology of GPR55","volume":"30","author":"Ross","year":"2008","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.ejphar.2013.08.039_bib27","doi-asserted-by":"crossref","first-page":"G357","DOI":"10.1152\/ajpgi.00456.2007","article-title":"Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis","volume":"294","author":"Siegmund","year":"2008","journal-title":"American Journal of Physiology\u2014Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.ejphar.2013.08.039_bib28","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/jnci\/92.14.1136","article-title":"15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells","volume":"92","author":"Shureiqi","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.ejphar.2013.08.039_bib29","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1124\/jpet.107.119412","article-title":"Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells","volume":"321","author":"Thomas","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.ejphar.2013.08.039_bib30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/mc.20515","article-title":"Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes","volume":"48","author":"Van Dross","year":"2009","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.ejphar.2013.08.039_bib101","doi-asserted-by":"crossref","unstructured":"Wolchok, J.D., Saenger, Y.M., 2007. Current topics in melanoma. Current Opinion in Oncology 19, 116\u2013120.","DOI":"10.1097\/CCO.0b013e32801497c6"},{"key":"10.1016\/j.ejphar.2013.08.039_bib31","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-07-6594","article-title":"The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development","volume":"68","author":"Zheng","year":"2008","journal-title":"Cancer Research"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913006481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913006481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T23:26:42Z","timestamp":1539386802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913006481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":32,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0014299913006481"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.08.039","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer activity of anandamide in human cutaneous melanoma cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}